Back to Journals » International Journal of Nanomedicine » Volume 9 » Issue 1

Acute toxicity of nickel nanoparticles in rats after intravenous injection

Authors Magaye RR, Yue X, Zou B, Shi H, Yu H, Liu K, Lin X, Xu J, Yang C, Wu A, Zhao J

Received 18 October 2013

Accepted for publication 12 December 2013

Published 12 March 2014 Volume 2014:9(1) Pages 1393—1402

DOI https://doi.org/10.2147/IJN.S56212

Checked for plagiarism Yes

Review by Single-blind

Peer reviewer comments 4

Ruth R Magaye,1,* Xia Yue,1,* Baobo Zou,1 Hongbo Shi,1 Hongsheng Yu,2 Kui Liu,1 Xialu Lin,1 Jin Xu,1 Cui Yang,3 Aiguo Wu,3 Jinshun Zhao1

1Public Health Department, 2Affiliated Hospital of Medical School, Zhejiang Provincial Key Laboratory of Pathological and Physiological Technology, Ningbo University, 3Key Laboratory of Magnetic Materials and Devices, Division of Functional Materials and Nano-devices, Ningbo Institute of Materials Technology and Engineering (NIMTE), Chinese Academy of Sciences, Ningbo, People's Republic of China

*These authors contributed equally to this work

Abstract: This study was carried out to add scientific data in regard to the use of metallic nanoparticles in nanomedicine. The acute toxicity of nickel (Ni) nanoparticles (50 nm), intravenously injected through the dorsal penile vein of Sprague Dawley rats was evaluated in this study. Fourteen days after injection, Ni nanoparticles induced liver and spleen injury, lung inflammation, and caused cardiac toxicity. These results indicate that precautionary measures should be taken with regard to the use of Ni nanoparticles or Ni compounds in nanomedicine.

Keywords: nickel, nanoparticles, intravenous, acute toxicity

Creative Commons License This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.

Download Article [PDF]  View Full Text [HTML][Machine readable]